Multiple sclerosis medication gap: Study finds women less likely than men to receive drugs

Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women's childbearing years, even when those drugs have been shown to be safe for use during pregnancy or to have a prolonged effect against the disease even when stopped before conception, according to a study published in Neurology.
👉 Full Story

United Health Group Stock Drops 50% and Moody’s Lowers US Credit Rating
- ChatGPT just got smarter: OpenAI’s Study Mode helps students learn step-by-step - Michael Nuñez
- Adapting to Market Changes: The Bitcoin Ordinals Gaming Project Bits - Christian J. Cunningham
- Mark Zuckerberg shares a confusing vision for AI 'superintelligence' - Karissa Bell
- Exploring the New Generative AI Features in Google Chrome - Sean George
- Another Mass Shooting, Another Butcher’s Bogus Rationale - Debra J. Saunders
- Google's New Machine Learning Algorithm is A Weapon Against Fake Reviews - Michael A. Medeiros

Hangry Karen pulls gun at McDonald’s, demands Egg McMuffin
- Signs and Symptoms of Inflammatory Bowel Disease (IBD) - Lindsay Curtis
- Deepfake Voices: A New Challenge for Detection Technologies - Michael Terry
- The Fastest Way to Earn $1,000 a Month as an Affiliate Marketer - Zoul
- The Wishlist for the Next Big Monster Hunter Game - Michael A. Medeiros
- BBC’s Laura Kuenssberg stunned as Reform share plans for legal cases against government - Isaiah Amos
- Google confirms it will sign the EU AI Code of Practice - Ryan Whitwam